Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
Rajiv Khanna(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), Scott C. Bell(Griffith University), Martina A. Sherritt(The University of Queensland), Lee Rafter(The University of Queensland), R. Slaughter(The University of Queensland), Scott R. Burrows(Australian National University), Trevor J. Williams(St. George's University), Michael C. Falk(The University of Queensland), Belinda E. Clarke(The University of Queensland), John Aubrey Douglass(The Alfred Hospital), Andrew Galbraith(The University of Queensland), Suzanne Elliott(The University of Melbourne)
Cited by 332
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
|The Lancet Respiratory Medicine|2014|442
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391